NR4A2 and adenoma: Nr4a2 has been reported to upregulate aldosterone synthase expression in NCI-H295R cells and proposed to have clinical importance, since its expression levels are upregulated in aldosterone-producing adenomas and correlate with aldosterone synthase expression levels (29, 30).